Jeffrey A. Vos
- Internal Medicine top 5%
- Hematology top 5%
- Acute Myeloid Leukemia Research 7
- Hematopoietic Stem Cell Transplantation 4
- Emergency Medicine top 5%
- Biochemistry top 10%
-
- Lymphoma Diagnosis and Treatment 6
-
- Sarcoma Diagnosis and Treatment 4
- Medical Imaging and Pathology Studies 3
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 2
-
- Viral-associated cancers and disorders 3
-
- Chronic Lymphocytic Leukemia Research 2
- Co-authors
- Nadine S. AguileraJo‐Ann W. AndrikoSusan L. AbbondanzoMarkku MiettinenWenjun Z. MartiniMyung S. ParkSaulius ButenasAnthony E. Pusateri
- Journals
- Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (3 papers)PLoS ONE (1 paper)
- Partner nations
- United StatesPakistanNigeria
In The Last Decade
Jeffrey A. Vos
34 papers receiving 781 citations
Peers
Comparison fields: 5 of 84
- Critical Care and Intensive Care Medicine 191
- Internal Medicine 100
- Hematology 157
- Emergency Medicine 110
- Biochemistry 49
Countries citing papers authored by Jeffrey A. Vos
This map shows the geographic impact of Jeffrey A. Vos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey A. Vos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey A. Vos more than expected).
Fields of papers citing papers by Jeffrey A. Vos
This network shows the impact of papers produced by Jeffrey A. Vos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey A. Vos. The network helps show where Jeffrey A. Vos may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jeffrey A. Vos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 4 | |
| 3 | 2023 | 0 | |
| 4 | 2022 | 13 | |
| 5 | 2022 | 0 | |
| 6 | 2021 | 8 | |
| 7 | 2019 | 11 | |
| 8 | 2019 | 19 | |
| 9 | 2018 | 1 | |
| 10 | 2016 | 14 | |
| 11 | 2015 | 6 | |
| 12 | Myeloid Sarcoma of the Bladder in the Setting of Refractory Anemia with Excess Blasts-2 (RAEB-2). | 2015 | 3 |
| 13 | 2015 | 0 | |
| 14 | 2014 | 20 | |
| 15 | 2012 | 10 | |
| 16 | 2010 | 28 | |
| 17 | 2009 | 273 | |
| 18 | 2005 | 69 | |
| 19 | 2005 | 167 | |
| 20 | 2003 | 13 |
About Jeffrey A. Vos
Jeffrey A. Vos is a scholar working on Hematology, Internal Medicine and Genetics, having authored 40 papers that have together received 797 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (7 papers), Lymphoma Diagnosis and Treatment (6 papers), Hematopoietic Stem Cell Transplantation (4 papers), Sarcoma Diagnosis and Treatment (4 papers), Viral-associated cancers and disorders (3 papers), Medical Imaging and Pathology Studies (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (191 citations), Internal Medicine (100 citations) and Hematology (157 citations). Jeffrey A. Vos has collaborated with scholars based in United States, Pakistan and Nigeria. Frequent co-authors include Nadine S. Aguilera, Jo‐Ann W. Andriko, Susan L. Abbondanzo, Markku Miettinen, Wenjun Z. Martini, Myung S. Park, Saulius Butenas, Anthony E. Pusateri, José Salinas and Steven E. Wolf. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.